In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vulnerable Plaque Heats Up

Executive Summary

Vulnerable plaque is the hottest cardiovascular device opportunity in years. But in shifting thinking about coronary disease from structural to biological processes, it challenges what it means to be a device company. As more evidence suggests vulnerable plaque is a systemic rather than local problem and as the underlying assumptions about coronary disease shift from a structural view to a biological one, conventional device approaches are challenged.
Advertisement

Related Content

On The Hunt For Vulnerable Plaque InfraReDx Improves Stenting Safety
World Congress of Cardiology: DES Safety Dominates Discussions
InfraReDx: Saved by Angels (and a VC)
Volcano's Second Act
Magnetic Moment
Guidant Shines Light on Vulnerable Plaque with Miravant Deal
Volcano Steps Up in Vulnerable Plaque By Buying Jomed's IVUS Business
Our Top Ten Items from a Year Most Want to Forget
Growing Companies--Part 1
The Coming of Age of Vulnerable Plaque

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel